Critical Role of Automation in Vein-to-Vein Manufacturing of Cell & Gene Therapies

Advancing the discussions around this critical topic, the 3rd Annual Automation spotlight focuses on the latest developments including:

  • Critical analysis of the different approaches to automation - balancing the need for flexibility with quality control and cost-effective scaleability with an indpeth look at the pros and cons of end-to-end automated manufacturing solutions vs integrated platforms.
  • The latest advances in automation across various cell therapy manufacturing platforms and bioprocesses including cell culture and expansion, analytical and characterization tools, process monitoring and control.
  • The key considerations when deciding to automate a complex biomanufacturing process such as autologous cell therapy manufacture, with in-depth discussion of the impact on cost of goods and risk management.